Status:
COMPLETED
Implementation of Caring Contacts
Lead Sponsor:
Sunnybrook Health Sciences Centre
Conditions:
Psychiatric Hospitalization
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This quality improvement (QI) project will adapt and improve an evidence-based suicide-prevention initiative for Sunnybrook patients at high risk of suicide following psychiatric inpatient discharge, ...
Eligibility Criteria
Inclusion
- Provision of written informed consent
- Age 18 or above
- Ability to read and understand English
- Have an email address
- The ability to understand and comply with the requirements of the project and capable of providing informed consent
- For inclusion in the outpatient focus groups participants must additionally have previous lived experience of psychiatric hospitalization with suicidal ideation or behaviour.
- For inclusion in the inpatient focus groups during phase one and for inclusion in the second and third phases of the project, participants must additionally 1) be an inpatient on the Sunnybrook Adult Inpatient Psychiatry Unit at the time of recruitment and 2) they must have been admitted to the unit with suicidal ideation or behaviour as determined by their C-SSRS score at admission.
Exclusion
- A primary diagnosis of a Major Neurocognitive Disorder
Key Trial Info
Start Date :
April 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT05294549
Start Date
April 11 2022
End Date
May 31 2023
Last Update
July 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4H 1R1